SLC2A3 and colorectal carcinoma: Our findings indicated upregulated expression of SLC2A3, MMP11, SCARA3, GPC1, OLFM2, L1CAM, and CRABP2 in CRC cells, with the expression of PHGR1, TFF1, and CLCA1 being diminished.